NEW DELHI (India CSR): Torrent Pharmaceuticals Limited has reinforced its standing as a socially responsible corporate leader by investing Rs 35.03 crores in Corporate Social Responsibility (CSR) initiatives during the financial year 2024-25. This contribution not only went beyond its statutory obligation under the Companies Act, 2013, but also underlined the company’s expanding commitment to building a healthier, more inclusive, and sustainable society.
At the core of Torrent Pharma’s CSR vision is the belief that business growth must go hand in hand with social progress. Guided by its philosophy of “Happiness for All”, the company has directed its CSR efforts toward some of the nation’s most pressing needs—advanced paediatric healthcare, environmental sustainability, education, and rural community development. In doing so, Torrent has impacted thousands of lives across India, setting a benchmark for responsible corporate citizenship.
Exceeding the Social Mandate
Torrent Pharmaceuticals’ CSR obligation for FY 2024-25 was Rs 33.31 crores, calculated as 2% of its average net profit of Rs 1,665.67 crores from the previous three years. In line with its philosophy of “Concern for Society & Environment,” the company spent Rs 35.03 crores, surpassing the minimum requirement.
This surplus commitment indicates not just compliance, but a deliberate choice to invest in India’s future. Importantly, the company also transferred Rs 10.78 crores of unspent obligation into a designated Unspent CSR Account for ongoing projects, ensuring transparency and accountability.
Flagship CSR Programme: REACH – Advanced Paediatric Healthcare
One of Torrent Pharma’s most impactful initiatives is its flagship REACH (Reach EAch CHild) Programme, which accounted for Rs 19.59 crores of total CSR expenditure in FY 2025.
Upgrading Paediatric Healthcare Infrastructure
At the centre of this initiative is the UNM Children Hospital in Kamrej, Gujarat, an upgraded facility evolved from the Sugen Paediatric Centre. Torrent invested heavily in advanced infrastructure, including:
- A Linde liquid oxygen tank to ensure uninterrupted supply of medical oxygen.
- A fourth modular operating theatre with a Carl Zeiss TIVATO 700 surgical microscope for advanced paediatric surgeries.
- Diagnostic services at the hospital achieving NABL certification, reinforcing quality and trust.
- Acquisition of vital capital assets such as a new hospital building (₹50.01 lakhs), ICU-equipped ambulance (₹57.28 lakhs), and IT infrastructure.
The hospital has become a centre of excellence, attracting children in need of critical care from across India.
Community Outreach through Camps
Beyond hospital walls, Torrent conducted paediatric surgical screening camps in rural districts like Narmada and Chhota Udepur. These camps reached more than 2,100 villages, screening children aged 6 months to 6 years for anaemia, malnutrition, and congenital health issues.
By focusing on preventive and surgical care, Torrent Pharma has successfully expanded its healthcare footprint, creating long-term social value.
Green Investments: Pratiti – Building Smarter Communities
Torrent Pharma also made a significant environmental and community development contribution through its Pratiti initiative, with a total investment of Rs 12.48 crores in FY 2025.
Urban Green Spaces and Public Parks
Phase III of Pratiti focused on developing public parks, gardens, ponds, and lakes. These urban green projects not only beautify neighborhoods but also recharge groundwater, improve air quality, and promote healthier lifestyles.
Local Development near Manufacturing Units
Torrent ensured CSR efforts extended to communities surrounding its manufacturing plants. Investments included:
- Rs 1.11 crores in Sikkim.
- Rs 1 crore in Baddi.
- Rs 0.10 crores across Dahej, Vizag, and Pithampur plants.
These funds supported school upgrades, panchayat infrastructure, and public amenities, directly benefiting local populations.
In total, Torrent created or acquired 90 capital assets through CSR in FY 2025, strengthening both healthcare and environmental ecosystems.
Investing in India’s Pharma Talent Pipeline
A forward-looking CSR highlight was Torrent Pharma’s contribution to the Foundation for Pharmaceutical Academy for Global Excellence (PAGE Foundation).
- The company allocated Rs 10 crores for the initiative.
- In FY 2025, it spent Rs 0.27 crores, primarily for land acquisition in Hyderabad (Rs 5.32 lakhs), laying the foundation for a dedicated skilling institute in collaboration with the Indian Pharmaceutical Alliance (IPA).
This project aims to bridge the skill gap in India’s pharmaceutical sector, nurturing a new generation of professionals with cutting-edge expertise.
Governance, Compliance, and Accountability
Torrent Pharma continues to view CSR as an extension of its Social and Relationship Capital, emphasizing governance and accountability.
- All CSR activities were aligned with statutory focus areas under Schedule VII of the Companies Act, 2013.
- The company ensured timely transfer of Rs 10.78 crores unspent CSR obligation for ongoing projects into the mandated CSR account.
- Detailed disclosures in its Integrated Annual Report 2024-25 reflect transparency, ensuring stakeholders can track the social impact of every rupee spent.
This approach reinforces stakeholder confidence and ensures alignment with India’s broader sustainable development goals.
Torrent Pharma’s CSR Spending at a Glance (FY 2024-25)
| CSR Focus Area | Amount (₹ Crores) | Key Highlights |
|---|---|---|
| Paediatric Healthcare (REACH) | 19.59 | UNM Children Hospital, surgical screening camps, ICU ambulance |
| Pratiti – Public Park Development | 12.48 | Urban green projects, water conservation |
| Community Development near Plants | 2.21 | Schools, panchayat infrastructure, public amenities |
| PAGE Foundation (Pharma Talent) | 0.27 | Land acquisition for skilling institute |
| Total CSR Spend | 35.03 | Surpassed statutory requirement of ₹33.31 crores |
Human-Centered Approach: Why Torrent’s CSR Matters
While numbers highlight compliance and scale, the true value of Torrent’s CSR lies in its human impact. By focusing on children’s healthcare, the company is directly preserving India’s future generations. By creating greener spaces, it improves quality of life in cities. By investing in skill development, it ensures employability for tomorrow’s workforce.
Torrent’s CSR model demonstrates that business success and community well-being can be mutually reinforcing goals.
You Learn
Torrent Pharmaceuticals’ CSR spending of Rs 35.03 crores in FY 2025 is a testament to its philosophy of responsibility, compassion, and long-term vision. With projects spanning healthcare, environment, education, and skill-building, Torrent continues to evolve as a corporate leader that prioritizes people as much as profits.
In an era where stakeholders increasingly demand accountability and impact, Torrent Pharma stands as a model of how businesses can meaningfully contribute to India’s sustainable development journey.
Frequently Asked Questions (FAQs): Torrent Pharmaceuticals Limited (TPL) FY 2024-25
Q1: What was Torrent Pharmaceuticals Limited’s total Corporate Social Responsibility (CSR) spending in FY 2024-25 compared to its statutory obligation?
Torrent Pharmaceuticals Limited’s statutory CSR obligation for the financial year 2024-25 was Rs 33.31 crores, calculated as two percent of the preceding three years’ average net profit of Rs 1,665.67 crores. The total amount the company spent on CSR projects (both ongoing and otherwise) during the year was Rs 35.03 crores, thereby fulfilling and exceeding its minimum obligation.
Q2: What is TPL’s primary focus area for its CSR investments, and how much was allocated to it?
The flagship CSR program is REACH – Reach EAch CHild, which operates under the UNM Foundation. The largest dedicated CSR expenditure was Rs 19.59 crores, allocated specifically to the REACH – Paediatric Healthcare Programme (Phase II). This program focuses on critical initiatives, including reducing malnutrition and anemia in children and providing specialized medical services through the UNM Children Hospital and Paediatric Primary Health Centres (PHCs).
Q3: What are the foundational principles guiding Torrent Pharma’s overall Corporate Governance framework?
Torrent Pharma’s corporate governance philosophy is rooted in three inviolable principles: Transparency, Integrity, and Accountability. The company aims to operate reliably, responsibly, and resiliently, guided by its simple and powerful purpose: ‘Happiness for All’.
Q4: Did the company create any capital assets through its CSR spending in FY 2024-25?
Yes, the company confirmed that it created or acquired capital assets through its CSR expenditure during the financial year. A total of 90 capital assets were created or acquired. This included procuring a building (Rs 50.01 lakhs) and vehicles (Rs 57.28 lakhs) for the UNM Children Hospital, and acquiring land (Rs 5.32 lakhs) for the PAGE Foundation.
Q5: What were the key consolidated financial performance indicators reported for the Group in FY 2024-25?
For the consolidated Group operations in FY 2024-25, key performance indicators included Revenue of Rs 11,516 crores, Operating EBITDA (Earnings before Interest, Taxes, Depreciation, and Amortisation) of Rs 3,721 crores, and Profit After Tax (PAT) of Rs 1,911 crores.
(India CSR)
